IMHO, NDTP/CCA,LLC/UPennMed's JV product(s) my be on the market in weeks, if not months and the License-able Biotech may already be in NDA-confidential negotiations with 300 Bil dollar drug firms like Novartis.
If I am right, we will not know until it is too late, just like the Kodak News that rallied the stock 200% in one day on a Gift form the US Gov last week, of over 500 Mil dollars to save Kodak from BK, and that put them in the business overnight night of making generic drug components for the US Gov.
I gave up my Kodak stock way too soon. Last week's Kodak news was not on my bingo card. NDTP is on my bingo card, the whole page is NDTP.
LOL
What if UPennMed is funding and getting shares in NDTP for their part of the CCA, LLC UPennMed JV Biotech assets????
Just a thought, but it is also on my "possible" Bingo card.
If that happens, if I am right and that happens, it will add huge credibility to the tech and NDTP stock value.
The second largest largest shareholder of the firm R/M here is also a director of the UPennMed research Hospital Trust that manages UPennMed IP=Patent and research assets and they are a 50/50 partner with CCA, LLC the form Hovis runs, as he now runs NDTP.
There are only three dots to connect, UPennMed-NDTP-CCA,LLC and Hovis runs two of them, and Mathias is number II on the CCA, LLC list and he is a director of the UPennMed Trust.
They are running out of things on the to list, just a Huge SEC filing left now to confirm what we know is coming, and has arrived.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
